Risk factors for upstaging, recurrence, and mortality in clinical T1-2 renal cell carcinoma patients upstaged to pT3a disease: an international analysis utilizing the 8th …
Objective To investigate risk factors for and outcomes in pathological T3a-upstaging in
Renal Cell Carcinoma (RCC), as Tumor-Node-Metastasis staging for T3a RCC was recently …
Renal Cell Carcinoma (RCC), as Tumor-Node-Metastasis staging for T3a RCC was recently …
Partial nephrectomy is associated with higher risk of relapse compared with radical nephrectomy for clinical stage T1 renal cell carcinoma pathologically up staged to …
PH Shah, DM Moreira, VR Patel, G Gaunay… - The Journal of …, 2017 - auajournals.org
Purpose: We studied recurrence-free survival after partial vs radical nephrectomy for clinical
stage T1 renal cell carcinoma in all patients and in those up staged to pathological stage …
stage T1 renal cell carcinoma in all patients and in those up staged to pathological stage …
Raman optical identification of renal cell carcinoma via machine learning
C He, X Wu, J Zhou, Y Chen, J Ye - Spectrochimica Acta Part A: Molecular …, 2021 - Elsevier
High pathologic tumor-node-metastasis (pTNM) stage grade or Fuhrman grade indicates
poor oncological outcome in renal cell carcinoma (RCC). Early diagnosis and screening of …
poor oncological outcome in renal cell carcinoma (RCC). Early diagnosis and screening of …
Oncological outcomes of patients with different pathological features of pT3a renal tumor: a systematic review and quantitative synthesis
P Guo, Y Wang, Y Han, D Wei, J Zhao, M Li… - Frontiers in …, 2021 - frontiersin.org
Purpose To identify the differences in oncological outcomes for patients with different pT3a
renal tumor invasion patterns and pathological features. Methods The protocol of this study …
renal tumor invasion patterns and pathological features. Methods The protocol of this study …
Prognostic evaluation of perinephric fat, renal sinus fat, and renal vein invasion for patients with pathological stage T3a clear‐cell renal cell carcinoma
Objective To investigate the prognostic significance of various patterns of extrarenal
extension that comprise pathological stage T3a clear‐cell renal cell carcinoma (ccRCC) …
extension that comprise pathological stage T3a clear‐cell renal cell carcinoma (ccRCC) …
Perioperative morbidity, oncological outcomes and predictors of pT3a upstaging for patients undergoing partial nephrectomy for cT1 tumors
Objectives To evaluate perioperative morbidity, oncological outcome and predictors of pT3a
upstaging after partial nephrectomy (PN). Materials and methods Retrospective study of …
upstaging after partial nephrectomy (PN). Materials and methods Retrospective study of …
Pathological T3a upstaging of clinical T1 renal cell carcinoma: outcomes according to surgical technique and predictors of upstaging
S Jeong, JK Kim, J Park, HJ Jeon, MY Yoon… - PLoS …, 2016 - journals.plos.org
Purpose To evaluate the prognosis of pT3a upstaging from cT1 renal cell carcinoma, and to
compare the outcomes of partial or radical nephrectomy in cases of pT3a upstaging …
compare the outcomes of partial or radical nephrectomy in cases of pT3a upstaging …
Interleukin-2 chronotherapy for metastatic renal cell carcinoma: results of a phase I-II study
GL Re, DA Santeufemia, FL Re, R Bortolus, P Doretto… - Cytokine, 2020 - Elsevier
Abstract Background Interleukin-2 (IL-2) was the cornerstone treatment for metastatic renal
cell carcinoma (RCC) until the advent of tyrosine kinase inhibitors, but it still has therapeutic …
cell carcinoma (RCC) until the advent of tyrosine kinase inhibitors, but it still has therapeutic …
Oncologic outcomes of partial nephrectomy for stage T3a renal cell cancer
A Shvero, O Nativ, Y Abu-Ghanem, D Zilberman… - Clinical Genitourinary …, 2018 - Elsevier
Background Partial nephrectomy (PN) for clinical stage T3 tumors is controversial. Radical
nephrectomy (RN) has been associated with a greater rate of chronic kidney disease, an …
nephrectomy (RN) has been associated with a greater rate of chronic kidney disease, an …
Added value of systemic inflammation markers in predicting clinical stage T1 renal cell carcinoma pathologically upstaged to T3a
H Liu, Z Wang, E Peng, Z Chen, K Tang, D Xia - Frontiers in Oncology, 2021 - frontiersin.org
Objectives We aimed to determine preoperative risk factors associated with pathologic T3a
(pT3a) upstaging of clinical T1 (cT1) renal cell carcinomas (RCCs) and develop a novel …
(pT3a) upstaging of clinical T1 (cT1) renal cell carcinomas (RCCs) and develop a novel …